Related Experiment Video
Updated: Aug 2, 2025

11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.1K
Disability accrual in primary and secondary progressive multiple sclerosis
Sam Harding-Forrester1, Izanne Roos1,2, Ai-Lan Nguyen1,2
1CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
Journal of Neurology, Neurosurgery, and Psychiatry
|April 17, 2023
Summary
Secondary progressive multiple sclerosis (SPMS) begins later and progresses slower than primary progressive multiple sclerosis (PPMS). This finding is crucial for understanding disease trajectories and clinical trial design in multiple sclerosis.
Area of Science:
- Neurology
- Clinical Research
- Epidemiology
Background:
- Comparing primary progressive multiple sclerosis (PPMS) and secondary progressive multiple sclerosis (SPMS) has been challenging due to varying diagnostic criteria and cohort effects.
- Previous studies reported conflicting findings regarding the age of onset and disability accrual rates between PPMS and SPMS.
Purpose of the Study:
- To compare the age of onset for the progressive phase and the rate of disability accrual between PPMS and operationally diagnosed SPMS.
- To analyze disability trajectories in different multiple sclerosis phenotypes using a large international cohort.
Main Methods:
- Utilized the international, clinic-based MSBase cohort, including patients with PPMS or SPMS diagnosed since 1995.
- Employed Andersen-Gill hazard ratios to estimate disability accrual rates on the Expanded Disability Status Scale (EDSS), adjusting for multiple covariates.
- Estimated ages at onset of the progressive phase using Kaplan-Meier analysis and ages at EDSS milestones with Turnbull analysis.
Main Results:
- SPMS cases (n=2575) had a later median onset of the progressive phase (46.7 years) compared to PPMS cases (n=1872, 43.9 years).
- SPMS showed slower disability accrual (HR 0.86) despite greater baseline disability.
- Age at wheelchair dependence was similar between PPMS and SPMS.
Conclusions:
- SPMS is characterized by a later onset and slower disability progression compared to PPMS.
- Convergent disability trajectories may result from later onset balancing greater baseline disability in SPMS.
- Distinct disability accrual rates necessitate careful consideration when combining PPMS and SPMS in clinical trials.
Keywords:
multiple sclerosisRelated Concept Videos
Parkinson's Disease: Overview
628
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
628
Myasthenia Gravis: Overview and Treatment
1.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.7K

